|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 451.82 USD | +0.75% |
|
+2.43% | +5.60% |
| 26/11 | Chemed Insider Sold Shares Worth $875,100, According to a Recent SEC Filing | MT |
| 12/11 | Chemed Corporation Presents at UBS Global Healthcare Conference 2025, Nov-11-2025 02:00 PM |
| Capitalization | 637.47Cr 547.01Cr 509.31Cr 473.96Cr 884.46Cr 58TCr 953.46Cr 5.86TCr 2.3TCr 28TCr 2.39TCr 2.34TCr 1,00900Cr | P/E ratio 2025 * |
23.3x | P/E ratio 2026 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise value | 637.47Cr 547.01Cr 509.31Cr 473.96Cr 884.46Cr 58TCr 953.46Cr 5.86TCr 2.3TCr 28TCr 2.39TCr 2.34TCr 1,00900Cr | EV / Sales 2025 * |
2.5x | EV / Sales 2026 * | 2.35x |
| Free-Float |
39.22% | Yield 2025 * |
0.49% | Yield 2026 * | 0.54% |
More valuation ratios
* Estimated data
More news
Last Transcript: Chemed Corporation
More recommendations
More press releases
More news
| 1 day | +0.75% | ||
| 1 week | +2.43% | ||
| Current month | +5.60% | ||
| 1 month | +5.06% | ||
| 3 months | +5.16% | ||
| 6 months | -1.76% | ||
| Current year | +5.60% |
| 1 week | 438.78 | 454.96 | |
| 1 month | 421.34 | 454.96 | |
| Current year | 421.34 | 454.96 | |
| 1 year | 408.42 | 623.6 | |
| 3 years | 408.42 | 654.62 | |
| 5 years | 403 | 654.62 | |
| 10 years | 124.77 | 654.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin McNamara
CEO | Chief Executive Officer | 72 | 01/05/2001 |
Michael Witzeman
DFI | Director of Finance/CFO | 54 | - |
Lisa Reinhard
ADM | Chief Administrative Officer | 53 | 01/11/1994 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hutton
BRD | Director/Board Member | 75 | 01/01/1985 |
Andrea Lindell
BRD | Director/Board Member | 82 | 01/05/2008 |
Kevin McNamara
BRD | Director/Board Member | 72 | 01/01/1987 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.75% | +2.43% | -14.77% | -9.17% | 632.7Cr | ||
| -0.10% | -0.98% | +55.38% | +84.97% | 11TCr | ||
| -1.67% | -1.70% | +53.98% | -11.78% | 10TCr | ||
| +1.44% | +7.31% | +50.49% | +84.26% | 3.36TCr | ||
| -0.46% | +4.58% | -12.20% | +18.69% | 2.44TCr | ||
| +3.16% | +0.61% | +11.92% | +4.09% | 2.11TCr | ||
| +3.78% | +3.50% | +21.26% | +26.25% | 2TCr | ||
| -2.01% | -6.27% | +50.99% | +277.32% | 1.75TCr | ||
| +0.30% | -5.08% | +54.80% | +53.38% | 1.65TCr | ||
| -6.02% | -8.08% | -14.87% | +12.30% | 1.28TCr | ||
| Average | -0.08% | +1.37% | +25.70% | +54.03% | 3.64TCr | |
| Weighted average by Cap. | -0.29% | +1.40% | +41.68% | +48.96% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 254.96Cr 218.78Cr 203.7Cr 189.56Cr 353.75Cr 23TCr 381.35Cr 2.34TCr 921.35Cr 11TCr 956.21Cr 936.5Cr 40TCr | 270.76Cr 232.34Cr 216.33Cr 201.31Cr 375.66Cr 24TCr 404.97Cr 2.49TCr 978.44Cr 12TCr 1.02TCr 994.52Cr 43TCr |
| Net income | 28Cr 24Cr 22Cr 21Cr 39Cr 2.52TCr 42Cr 256.26Cr 100.82Cr 1.2TCr 104.63Cr 102.47Cr 4.41TCr | 32Cr 27Cr 25Cr 23Cr 44Cr 2.85TCr 47Cr 290.26Cr 114.19Cr 1.36TCr 118.51Cr 116.07Cr 5TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
15,695
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 451.82 $ | +0.75% | 1,20,620 |
| 13/26/13 | 448.44 $ | +0.51% | 1,12,029 |
| 12/26/12 | 446.15 $ | +0.39% | 1,19,607 |
| 09/26/09 | 444.40 $ | -1.06% | 1,30,822 |
| 08/26/08 | 449.18 $ | +2.25% | 2,17,980 |
Delayed Quote Nyse, January 15, 2026 at 02:30 am IST
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
4
Last Close Price
451.82USD
Average target price
574.25USD
Spread / Average Target
+27.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CHE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















